Glycomine Revenue and Competitors
Estimated Revenue & Valuation
- Glycomine's estimated annual revenue is currently $1.9M per year.
- Glycomine's estimated revenue per employee is $77,500
- Glycomine's total funding is $80M.
Employee Data
- Glycomine has 24 Employees.
- Glycomine grew their employee count by -23% last year.
Glycomine's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP, Clinical Operations and Patient Advocacy | Reveal Email/Phone |
4 | VP, Preclinical Development | Reveal Email/Phone |
5 | VP, Regulatory Affairs | Reveal Email/Phone |
6 | Senior Director Process Development | Reveal Email/Phone |
7 | Sr. Director Analytical Development | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Glycomine Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Glycomine?
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine’s lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
keywords:N/A
$80M
Total Funding
24
Number of Employees
$1.9M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Glycomine News
It also participated in the Series B fundraising round for Glycomine, in which the rare disease biotech pulled in $35 million.
Other Companies in San Carlos
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.8M | 26 | 0% | N/A |
#2 | $4.3M | 28 | -12% | N/A |
#3 | $5M | 29 | 4% | N/A |
#4 | N/A | 29 | 4% | N/A |
#5 | N/A | 29 | 4% | N/A |